Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized trial of antiretroviral regimens with different CNS penetration in treatment-naive HIV patients
2012-003595-39Phase 4Active
- Sponsor
- FIBHULP
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in human immunodeficiency virus infection (HIV) comparing Atazanavir/ritonavir + abacavir/lamivudine with Efavirenz + emtricitabine/tenofovir disoproxil (2 arms). Primary endpoint: Change in N-acetyl-aspartate levels in the cerebral basal ganglia. Started Nov 2012; status: active.
02
Drugs
atazanavirritonavirabacavirlamivudineefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2012-003595-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003595-39.